Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

Fig. 2

Relationship between interim response status and a) plasma Cmax and b) CSF Cmax bendamustine concentrations, and tumor location. Deep structures include periventricular regions, basal ganglia, brainstem, and cerebellum regions. Closed circles (•) represent responders and open circles (°) non-responders. Patient identification numbers are notated and the dashed line depicts mean Cmax values for plasma and CSF. Bendamustine exposure was not significantly higher for the patient resulting in treatement related death (ID No. 8)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us